Taproot Management’s Zimmer Biomet ZBH Stock Holding History

Taproot Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-51,622	Closed	-$4.67M	–	173
2026 Q1	$4.67M	Buy	51,622 +29,909	+138%	+$2.74M	0.88%	36
2025 Q4	$1.95M	Buy	+21,713	New	+$2.06M	0.32%	102

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Taproot Management's ZBH Position: Q2 2026 in Review

Taproot Management sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 51,622 shares — an estimated $4.67M sold.

Taproot Management first reported a position in ZBH in Q4 2025 and held it in 2 quarters. The position peaked at $4.67M in Q1 2026. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Taproot Management reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
Taproot Management sold 51,622 Zimmer Biomet shares in Q2 2026, an estimated $4.67M.
Taproot Management first reported a position in Zimmer Biomet in Q4 2025 and held it in 2 quarters.
Taproot Management's Zimmer Biomet position peaked at $4.67M in Q1 2026.
906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Taproot Management's 13F filing for Q2 2026.